A review of the interaction among dietary antioxidants and reactive oxygen species

Journal of Nutritional Biochemistry

Volumn 18, Issue 9, 2007, Pages 567-579

  Seifried, Harold E ^a   Anderson, Darrell E ^b   Fisher, Evan I ^a   Milner, John A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Scientific Consulting Group Inc   (United States)

Author keywords

Antioxidants; Cancer; Cardiovascular disease; Reactive oxygen species; Review

Indexed keywords

ANTIOXIDANT; APOPTOSIS SIGNAL REGULATING KINASE 1; CASPASE 8; CATALASE; CHEMOKINE; CYTOKINE; DNA; EPIDERMAL GROWTH FACTOR RECEPTOR; FLAVANOID; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HYDROGEN PEROXIDE; HYDROXYL RADICAL; HYPOXIA INDUCIBLE FACTOR 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; ISOFLAVONE; METAL; MITOGEN ACTIVATED PROTEIN KINASE; PLANT EXTRACT; POLYPHENOL; PROTEIN P53; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; STRESS ACTIVATED PROTEIN KINASE; SUPEROXIDE; SUPEROXIDE DISMUTASE; THIOL DERIVATIVE; VITAMIN;

ADAPTIVE IMMUNITY; ANGIOGENESIS; ANTIOXIDANT ACTIVITY; APOPTOSIS; CANCER; CANCER CELL; CANCER INVASION; CANCER PREVENTION; CARCINOGENESIS; CARDIOVASCULAR DISEASE; CELL DAMAGE; CYTOKINE PRODUCTION; DIETARY INTAKE; DNA DAMAGE; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HEPATITIS B; HEPATITIS C; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INFLAMMATION; INFLUENZA; LIPID OXIDATION; METASTASIS; MORTALITY; NONHUMAN; OXIDATIVE STRESS; REVIEW; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE; VASCULAR SMOOTH MUSCLE; VIRAL RESPIRATORY TRACT INFECTION;

ANIMALS; ANTIOXIDANTS; CARDIOVASCULAR DISEASES; DIET; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 34547666796     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2006.10.007     Document Type: Review

References (98)

1. Cameron E., and Pauling L. Supplemental ascorbate in the supportive treatment of cancer: prolongation of survival times in terminal human cancer. Proc Natl Acad Sci U S A 73 (1976) 3685-3689
2. Wattenberg L.W. Inhibitors of chemical carcinogenesis. Adv Cancer Res 26 (1978) 197-226
3. Young V.R., and Newberne P.M. Vitamins and cancer prevention: issues and dilemmas. Cancer 47 (1981) 1226-1240
4. Ames B.N. Dietary carcinogens and anticarcinogens: oxygen radicals and degenerative diseases. Science 221 (1983) 1256-1264
5. Willett W.C., and MacMahon B. Diet and cancer - an overview (second of two parts). N Engl J Med 310 (1984) 697-703
6. Willett W.C., and MacMahon B. Diet and cancer - an overview. N Engl J Med 310 (1984) 633-638
7. American Institute of Cancer Research/World Cancer Research Fund. In: World Cancer Research Fund (Ed). Food, nutrition and the prevention of cancer: a global perspective (1997), American Institute for Cancer Research, Washington (DC)
8. Radimer K.L., Bindewald B., Hughes J., Ervin B., Swanson C., and Picciano M.F. Dietary supplement use by US adults: data from the National Health and Nutrition Examination Survey, 1999-2000. Am J Epidemiol 160 (2004) 339-349
9. Food and Drug Administration Office of Special Nutritionals. Conference on Antioxidant Vitamins and Cancer and Cardiovascular Disease, November 1-3, 1993. Washington (DC), Food and Drug Administration (1993)
10. Herbert V. The antioxidant supplement myth. Am J Clin Nutr 60 (1994) 157-158
11. Martindale J.L., and Holbrook N.J. Cellular response to oxidative stress: signaling for suicide and survival. J Cell Physiol 192 (2002) 1-15
12. Coulter I., Hardy M., Shekelle P.M., et al. Effects of the supplemental use of antioxidant vitamin C, vitamin E and coenzyme Q10 for the prevention and treatment of cancer. Evidence Report/Technology Assessment Number 75. AHRQ Publication No. 03-E047 (2003), Agency for Healthcare Research and Quality, Rockville (Md)
13. Finkel T. Oxygen radicals and signaling. Curr Opin Cell Biol 10 (1998) 248-253
14. Castro L, Freeman BA. Reactive oxygen species in human health and disease. Nutrition 2001;17:161,161-2,165
15. Seifried H.E., Anderson D.E., Milner J.A., and Greenwald P. Reactive oxygen species and dietary antioxidants: double-edged swords?. In: Panglossi H. (Ed). New developments in antioxidant research (2006), Nova Science Publishers Inc., Hauppauge (NY) 1-25
16. Finkel T., and Holbrook N.J. Oxidants, oxidative stress and the biology of ageing. Nature 408 (2000) 239-247
17. Holbrook N.J., and Ikeyama S. Age-related decline in cellular response to oxidative stress: links to growth factor signaling pathways with common defects. Biochem Pharmacol 64 (2002) 999-1005
18. Sohal R.S., and Weindruch R. Oxidative stress, caloric restriction, and aging. Science 273 (1996) 59-63
19. McCord J.M. The evolution of free radicals and oxidative stress. Am J Med 108 (2000) 652-659
20. Lopaczynski W., and Zeisel S.H. Antioxidants, programmed cell death, and cancer. Nutr Res 21 (2004) 295-307
21. Droge W. Free radicals in the physiological control of cell function. Physiol Rev 82 (2002) 47-95
22. Heeneman S., Haendeler J., Saito Y., Ishida M., and Berk B.C. Angiotensin II induces transactivation of two different populations of the platelet-derived growth factor beta receptor. Key role for the p66 adaptor protein Shc. J Biol Chem 275 (2000) 15926-15932
23. Bae Y.S., Kang S.W., Seo M.S., Baines I.C., Tekle E., Chock P.B., et al. Epidermal growth factor (EGF)-induced generation of hydrogen peroxide. Role in EGF receptor-mediated tyrosine phosphorylation. J Biol Chem 272 (1997) 217-221
24. Li J., and Holbrook N.J. Common mechanisms for declines in oxidative stress tolerance and proliferation with aging. Free Radic Biol Med 35 (2003) 292-299
25. Johnson G.L., and Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298 (2002) 1911-1912
26. Barrett W.C., De Gnore J.P., Keng Y.F., Zhang Z.Y., Yim M.B., and Chock P.B. Roles of superoxide radical anion in signal transduction mediated by reversible regulation of protein-tyrosine phosphatase 1B. J Biol Chem 274 (1999) 34543-34546
27. Barrett W.C., De Gnore J.P., Konig S., Fales H.M., Keng Y.F., Zhang Z.Y., et al. Regulation of PTP1B via glutathionylation of the active site cysteine 215. Biochemistry 38 (1999) 6699-6705
28. Schreck R., and Baeuerle P.A. A role for oxygen radicals as second messengers. Trends Cell Biol 1 (1991) 39-42
29. Kretz-Remy C., Bates E.E., and Arrigo A.P. Amino acid analogs activate NF-kappaB through redox-dependent IkappaB-alpha degradation by the proteasome without apparent IkappaB-alpha phosphorylation. Consequence on HIV-1 long terminal repeat activation. J Biol Chem 273 (1998) 3180-3191
30. Hirota K., Murata M., Sachi Y., Nakamura H., Takeuchi J., Mori K., et al. Distinct roles of thioredoxin in the cytoplasm and in the nucleus. A two-step mechanism of redox regulation of transcription factor NF-kappaB. J Biol Chem 274 (1999) 27891-27897
31. Pahl H.L. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18 (1999) 6853-6866
32. Bours V., Bonizzi G., Bentires-Alj M., Bureau F., Piette J., Lekeux P., et al. NF-kappaB activation in response to toxical and therapeutical agents: role in inflammation and cancer treatment. Toxicology 153 (2000) 27-38
33. Luo D., Vermijlen D., Vanderkerken K., Kuppen P.J., Seynaeve C., Eddouks M., et al. Involvement of LFA-1 in hepatic NK cell (pit cell)-mediated cytolysis and apoptosis of colon carcinoma cells. J Hepatol 31 (1999) 110-116
34. Aoki M., Nata T., Morishita R., Matsushita H., Nakagami H., Yamamoto K., et al. Endothelial apoptosis induced by oxidative stress through activation of NF-kappaB: antiapoptotic effect of antioxidant agents on endothelial cells. Hypertension 38 (2001) 48-55
35. Vollgraf U., Wegner M., and Richter-Landsberg C. Activation of AP-1 and nuclear factor-kappaB transcription factors is involved in hydrogen peroxide-induced apoptotic cell death of oligodendrocytes. J Neurochem 73 (1999) 2501-2509
36. Shou Y., Gunasekar P.G., Borowitz J.L., and Isom G.E. Cyanide-induced apoptosis involves oxidative-stress-activated NF-kappaB in cortical neurons. Toxicol Appl Pharmacol 164 (2000) 196-205
37. Bogdan C., Rollinghoff M., and Diefenbach A. Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity. Curr Opin Immunol 12 (2000) 64-76
38. Segal B.H., Leto T.L., Gallin J.I., Malech H.L., and Holland S.M. Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine (Baltimore) 79 (2000) 170-200
39. De Forge L.E., Preston A.M., Takeuchi E., Kenney J., Boxer L.A., and Remick D.G. Regulation of interleukin 8 gene expression by oxidant stress. J Biol Chem 268 (1993) 25568-25576
40. Ryan K.A., Smith Jr. M.F., Sanders M.K., and Ernst P.B. Reactive oxygen and nitrogen species differentially regulate Toll-like receptor 4-mediated activation of NF-kappa B and interleukin-8 expression. Infect Immun 72 (2004) 2123-2130
41. Liu T., Castro S., Brasier A.R., Jamaluddin M., Garofalo R.P., and Casola A. Reactive oxygen species mediate virus-induced STAT activation: role of tyrosine phosphatases. J Biol Chem 279 (2004) 2461-2469
42. Yoshida Y., Maruyama M., Fujita T., Arai N., Hayashi R., Araya J., et al. Reactive oxygen intermediates stimulate interleukin-6 production in human bronchial epithelial cells. Am J Physiol 276 (1999) L900-L908
43. Hsu H.Y., and Wen M.H. Lipopolysaccharide-mediated reactive oxygen species and signal transduction in the regulation of interleukin-1 gene expression. J Biol Chem 277 (2002) 22131-22139
44. Zhang B., Hirahashi J., Cullere X., and Mayadas T.N. Elucidation of molecular events leading to neutrophil apoptosis following phagocytosis: cross-talk between caspase 8, reactive oxygen species, and MAPK/ERK activation. J Biol Chem 278 (2003) 28443-28454
45. Hildeman D.A., Mitchell T., Teague T.K., Henson P., Day B.J., Kappler J., et al. Reactive oxygen species regulate activation-induced T cell apoptosis. Immunity 10 (1999) 735-744
46. Hehner S.P., Breitkreutz R., Shubinsky G., Unsoeld H., Schulze-Osthoff K., Schmitz M.L., et al. Enhancement of T cell receptor signaling by a mild oxidative shift in the intracellular thiol pool. J Immunol 165 (2000) 4319-4328
47. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 (2000) 57-70
48. Ohshima H., Tatemichi M., and Sawa T. Chemical basis of inflammation-induced carcinogenesis. Arch Biochem Biophys 417 (2003) 3-11
49. Marnett L.J. Oxyradicals and DNA damage. Carcinogenesis 21 (2000) 361-370
50. Collins A.R., Cadet J., Moller L., Poulsen H.E., and Vina J. Are we sure we know how to measure 8-oxo-7,8-dihydroguanine in DNA from human cells?. Arch Biochem Biophys 423 (2004) 57-65
51. Cadet J., Douki T., Gasparutto D., and Ravanat J.L. Oxidative damage to DNA: formation, measurement and biochemical features. Mutat Res 531 (2003) 5-23
52. Malins D.C., and Haimanot R. Major alterations in the nucleotide structure of DNA in cancer of the female breast. Cancer Res 51 (1991) 5430-5432
53. Shimoda R., Nagashima M., Sakamoto M., Yamaguchi N., Hirohashi S., Yokota J., et al. Increased formation of oxidative DNA damage, 8-hydroxydeoxyguanosine, in human livers with chronic hepatitis. Cancer Res 54 (1994) 3171-3172
54. Farinati F., Cardin R., Degan P., Rugge M., Mario F.D., Bonvicini P., et al. Oxidative DNA damage accumulation in gastric carcinogenesis. Gut 42 (1998) 351-356
55. Szatrowski T.P., and Nathan C.F. Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res 51 (1991) 794-798
56. Oberley T.D., and Oberley L.W. Antioxidant enzyme levels in cancer. Histol Histopathol 12 (1997) 525-535
57. Policastro L., Molinari B., Larcher F., Blanco P., Podhajcer O.L., Costa C.S., et al. Imbalance of antioxidant enzymes in tumor cells and inhibition of proliferation and malignant features by scavenging hydrogen peroxide. Mol Carcinog 39 (2004) 103-113
58. Arnold R.S., Shi J., Murad E., Whalen A.M., Sun C.Q., Polavarapu R., et al. Hydrogen peroxide mediates the cell growth and transformation caused by the mitogenic oxidase Nox1. Proc Natl Acad Sci U S A 98 (2001) 5550-5555
59. Suh Y.A., Arnold R.S., Lassegue B., Shi J., Xu X., Sorescu D., Chung A.B., et al. Cell transformation by the superoxide-generating oxidase Mox1. Nature 401 (1999) 79-82
60. Salganik R.I. The benefits and hazards of antioxidants: controlling apoptosis and other protective mechanisms in cancer patients and the human population. J Am Coll Nutr 20 (2001) 464S-472S
61. Salganik R.I., Solovyova N.A., Dikalov S.I., Grishaeva O.N., Semenova L.A., and Popovsky A.V. Inherited enhancement of hydroxyl radical generation and lipid peroxidation in the S strain rats results in DNA rearrangements, degenerative diseases, and premature aging. Biochem Biophys Res Commun 199 (1994) 726-733
62. Lee Y.J., Galoforo S.S., Berns C.M., Chen J.C., Davis B.H., Sim J.E., et al. Glucose deprivation-induced cytotoxicity and alterations in mitogen-activated protein kinase activation are mediated by oxidative stress in multidrug-resistant human breast carcinoma cells. J Biol Chem 273 (1998) 5294-5299
63. Wang X., Martindale J.L., Liu Y., and Holbrook N.J. The cellular response to oxidative stress: influences of mitogen-activated protein kinase signalling pathways on cell survival. Biochem J 333 Pt 2 (1998) 291-300
64. Brown N.S., and Bicknell R. Hypoxia and oxidative stress in breast cancer. Oxidative stress: its effects on the growth, metastatic potential and response to therapy of breast cancer. Breast Cancer Res 3 (2001) 323-327
65. Benhar M., Dalyot I., Engelberg D., and Levitzki A. Enhanced ROS production in oncogenically transformed cells potentiates c-Jun N-terminal kinase and p38 mitogen-activated protein kinase activation and sensitization to genotoxic stress. Mol Cell Biol 21 (2001) 6913-6926
66. Irani K., Xia Y., Zweier J.L., Sollott S.J., Der C.J., Fearon E.R., et al. Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts. Science 275 (1997) 1649-1652
67. Malafa M., Margenthaler J., Webb B., Neitzel L., and Christophersen M. MnSOD expression is increased in metastatic gastric cancer. J Surg Res 88 (2000) 130-134
68. Behrend L., Henderson G., and Zwacka R.M. Reactive oxygen species in oncogenic transformation. Biochem Soc Trans 31 (2003) 1441-1444
69. Li J.J., Colburn N.H., and Oberley L.W. Maspin gene expression in tumor suppression induced by overexpressing manganese-containing superoxide dismutase cDNA in human breast cancer cells. Carcinogenesis 19 (1998) 833-839
70. Calmels S., Hainaut P., and Ohshima H. Nitric oxide induces conformational and functional modifications of wild-type p53 tumor suppressor protein. Cancer Res 57 (1997) 3365-3369
71. Cobbs C.S., Samanta M., Harkins L.E., Gillespie G.Y., Merrick B.A., and MacMillan-Crow L.A. Evidence for peroxynitrite-mediated modifications to p53 in human gliomas: possible functional consequences. Arch Biochem Biophys 394 (2001) 167-172
72. Wiseman H., and Halliwell B. Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. Biochem J 313 Pt 1 (1996) 17-29
73. Wink D.A., Vodovotz Y., Laval J., Laval F., Dewhirst M.W., and Mitchell J.B. The multifaceted roles of nitric oxide in cancer. Carcinogenesis 19 (1998) 711-721
74. Dhar A., Brindley J.M., Stark C., Citro M.L., Keefer L.K., and Colburn N.H. Nitric oxide does not mediate but inhibits transformation and tumor phenotype. Mol Cancer Ther 2 (2003) 1285-1293
75. Laval F., and Wink D.A. Inhibition by nitric oxide of the repair protein O6-methylguanine-DNA-methyltransferase. Carcinogenesis 15 (1994) 443-447
76. Graziewicz M., Wink D.A., and Laval F. Nitric oxide inhibits DNA ligase activity: potential mechanisms for NO-mediated DNA damage. Carcinogenesis 17 (1996) 2501-2505
77. Kim Y.M., Talanian R.V., and Billiar T.R. Nitric oxide inhibits apoptosis by preventing increases in caspase-3-like activity via two distinct mechanisms. J Biol Chem 272 (1997) 31138-31148
78. Vasa M., Breitschopf K., Zeiher A.M., and Dimmeler S. Nitric oxide activates telomerase and delays endothelial cell senescence. Circ Res 87 (2000) 540-542
79. Seifried H.E., Anderson D.E., Sorkin B.C., and Costello R.B. Free radicals: the pros and cons of antioxidants. Executive summary report. J Nutr 134 (2004) 3143S-3163S
80. Itabe H. Oxidized low-density lipoproteins: what is understood and what remains to be clarified. Biol Pharm Bull 26 (2003) 1-9
81. Duval C., Cantero A.V., Auge N., Mabile L., Thiers J.C., Negre-Salvayre A., et al. Proliferation and wound healing of vascular cells trigger the generation of extracellular reactive oxygen species and LDL oxidation. Free Radic Biol Med 35 (2003) 1589-1598
82. Sullivan G.W., Sarembock I.J., and Linden J. The role of inflammation in vascular diseases. J Leukoc Biol 67 (2000) 591-602
83. Frostegard J., Wu R., Lemne C., Thulin T., Witztum J.L., and de Faire U. Circulating oxidized low-density lipoprotein is increased in hypertension. Clin Sci (Lond) 105 (2003) 615-620
84. Alexander R.W. Theodore Cooper Memorial Lecture. Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: a new perspective. Hypertension 25 (1995) 155-161
85. Cai H., and Harrison D.G. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 87 (2000) 840-844
86. Goldstein J.L., Ho Y.K., Basu S.K., and Brown M.S. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci U S A 76 (1979) 333-337
87. Kovanen P.T. The mast cell - a potential link between inflammation and cellular cholesterol deposition in atherogenesis. Eur Heart J 14 Suppl K (1993) 105-117
88. Rubanyi G.M., Romero J.C., and Vanhoutte P.M. Flow-induced release of endothelium-derived relaxing factor. Am J Physiol 250 (1986) H1145-H1149
89. Nakazono K., Watanabe N., Matsuno K., Sasaki J., Sato T., and Inoue M. Does superoxide underlie the pathogenesis of hypertension?. Proc Natl Acad Sci U S A 88 (1991) 10045-10048
90. Schachinger V., Britten M.B., and Zeiher A.M. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 101 (2000) 1899-1906
91. Kunsch C., and Medford R.M. Oxidative stress as a regulator of gene expression in the vasculature. Circ Res 85 (1999) 753-766
92. Takano H., Zou Y., Hasegawa H., Akazawa H., Nagai T., and Komuro I. Oxidative stress-induced signal transduction pathways in cardiac myocytes: involvement of ROS in heart diseases. Antioxid Redox Signal 5 (2003) 789-794
93. Irani K. Oxidant signaling in vascular cell growth, death, and survival: a review of the roles of reactive oxygen species in smooth muscle and endothelial cell mitogenic and apoptotic signaling. Circ Res 87 (2000) 179-183
94. Harrison D., Griendling K.K., Landmesser U., Hornig B., and Drexler H. Role of oxidative stress in atherosclerosis. Am J Cardiol 91 (2003) 7A-11A
95. Ushio-Fukai M., Alexander R.W., Akers M., and Griendling K.K. p38 Mitogen-activated protein kinase is a critical component of the redox-sensitive signaling pathways activated by angiotensin II. Role in vascular smooth muscle cell hypertrophy. J Biol Chem 273 (1998) 15022-15029
96. Johnson T.M., Yu Z.X., Ferrans V.J., Lowenstein R.A., and Finkel T. Reactive oxygen species are downstream mediators of p53-dependent apoptosis. Proc Natl Acad Sci U S A 93 (1996) 11848-11852
97. Li P.F., Dietz R., and von Harsdorf R. Differential effect of hydrogen peroxide and superoxide anion on apoptosis and proliferation of vascular smooth muscle cells. Circulation 96 (1997) 3602-3609
98. Li P.F., Dietz R., and von Harsdorf R. Reactive oxygen species induce apoptosis of vascular smooth muscle cell. FEBS Lett 404 (1997) 249-252